Travere Therapeutics Inc Cash Flow Reinvestment Rate
Travere Therapeutics Inc cash flow reinvestment rate. Travere Therapeutics Inc (TVTX) has a Cash Flow Reinvestment Rate of 3.57x as of June 2026, reinvesting $207.39 Million (capex $22.18 Million plus investments $-185.22 Million) from operating cash flow of $58.07 Million. Explore Travere Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Travere Therapeutics Inc (2017–2025)
Cash flow reinvestment rate of Travere Therapeutics Inc from 2017 to 2025. Historical reinvestment intensity for Travere Therapeutics Inc across 2 annual periods. Explore how much does Travere Therapeutics Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Travere Therapeutics Inc Cash Flow Reinvestment Rate by Year (2017–2025)
Travere Therapeutics Inc cash flow reinvestment rate by year from 2017 to 2025. Year-by-year capital reinvestment analysis for Travere Therapeutics Inc. For the full cash flow conversion analysis, see Travere Therapeutics Inc operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.83x | $144.61 Million | $37.78 Million | $58.16 Million | ▲ +8.5% |
| 2017 | 3.53x | $26.12 Million | $7.40 Million | $14.01 Million | — |